Fraser Health regional pre-printed orders for restricted antimicrobial drugs is immediately discontinued.

What’s happening?

The Student Practice Team would like to inform all students and faculty instructors that the following Clinical Decision Support Tool (CDST) has been discontinued immediately: Fraser Health Regional Pre-Printed Orders for Restricted Antimicrobial Drugs

Why is this important?

  • This impacts prescribing of carbapenems (meropenen, imipenem, ertapenem), linezolid, and daptomycin.
  • Province-wide restriction criteria for daptomycin and carbapenems have changed such that the current Pre-Printed Orders (PPOs) are no longer accurate.
  • Multiple audits have shown that this PPO is rarely used across Fraser Health, even when carbapenems, linezolid, or daptomycin are ordered.
  • Other antimicrobial stewardship strategies have been very effective in reducing carbapenem, linezolid, and daptomycin usage.

How will this impact students and faculty instructors?

Students and faculty instructors who are completing student placements in Fraser Health must consult with their clinical areas to determine what practices must be followed to ensure that our residents continue to receive safe and quality care.

  • Be aware of the updated province-wide restriction criteria for carbapenems and daptomycin, which are available on FH Pulse.
  • Prescription of carbapenems, linezolid, or daptomycin no longer requires completion of a special PPO. A standard order sheet can be used.
  • The Regional PPO for Parenteral Antibiotic Therapy Adult Outpatient is being revised to remove reference to the Restricted Antimicrobial Drug PPO for ertapenem. In the interim, ertapenem prescriptions should be written in full beside the section “Other:______”


Please contact the Student Practice Team at

comments powered by Disqus